BALTIMORE, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) is pleased to announce that Sarah E. McAchran, MD, FACS, has been named the 2026 AUA Gallagher Health Policy ...

Unlike in the general population, women with stage 5 chronic kidney disease (CKD) do not have a sex-based survival advantage compared with men.

Sprout Pharmaceuticals today announced a monumental milestone for women's health: the U.S. Food and Drug Administration (FDA) ...

Researchers report that yoga and general exercise deliver similar sleep outcomes for women managing urinary incontinence.

Men and women often experience similar bladder symptoms, but the causes are completely different. With insights from Dr ...

The FDA has expanded the approval of flibanserin (Addyi), a medication for low sexual desire in women, to include certain ...

Judson Mill has been honored. Bon Secours St. Francis Health System has begun construction. Habitat for Humanity of ...

At long last, desire gets its due.

Long regarded as mainly a male disease, kidney stone cases among women are increasing as lifestyles and the climate changes.

HSDD affects 40%-55% of postmenopausal women, often due to hormonal changes, impacting sexual desire and quality of life.

Lori Lerner, MD, associate professor of urology at Boston University Chobanian & Avedisian School of Medicine, is the recipient of the 2026 Distinguished Contribution Award from the American ...

The FDA has approved GSK's gepotidacin (Blujepa), the first new antibiotic class for gonorrhea in over three decades, ...